A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Ferric (Auryxia)

Uses For temporary relief of pain and itching associated with: minor burns sunburn minor cuts scrapes insect bites minor skin irritations rashes due to poison ivy, poison oak, or poison sumac Dries....

First FDA approval2014-09-17
Generic availableYes · 1 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$132.0M in CY2024 Part D spend73K claims · 17K beneficiaries · 329 plans surveyed

Lowest NADAC
$6.30/unit
2 NDCs benchmarked, lowest of all strengths.
Average NADAC
$6.89
Across all dosage forms in distribution.
Highest NADAC
$7.48
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Ferric used for?

Uses For temporary relief of pain and itching associated with: minor burns sunburn minor cuts scrapes insect bites minor skin irritations rashes due to poison ivy, poison oak, or poison sumac Dries....

Is there a generic for Ferric?

Yes. 1 ANDAs filed at FDA, 1 generic manufacturers currently shipping.

How much does my plan pay for Ferric?

Across 329 Part D plans, Ferric averages $6.89/unit (NADAC). Lowest available: $6.30/unit. Highest in distribution: $7.48/unit.

Is Ferric on the FDA shortage list?

No. Ferric is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (2 approvals on file) · NADAC unit costs: CMS NADAC weekly file (2 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.